Attenuated, streptomycin-dependent salmonella typhi oral vaccine: Potentialdeleterious effects of lyophilization

Myron M. Levine, Richard B. Hornick, Merrill J. Snyder, William Woodward, Robert H. Gilman, Joseph P. Libonati

Research output: Contribution to journalArticle

Abstract

Four studies were done with streptomycin-dependent Salmonella ty phi as an oral, attenuated vaccine. Studies 1 and 3 employed freshly harvested vaccine, whereas studies 2 and 4 involved lyophilized vaccine. Five to eight doses (3 X 1010—1011 organisms/dose) were given; oral streptomycin (1.0 g) was administered concomitantly in studies 2 and 3, with only two of the doses of vaccine in study 1, and was not given in study 4. No adverse reactions were encountered in 179 vaccinated men, and 94% of the men excreted the vaccine. In challenge studies (which included the control groups) with 105 virulent S. typhi organisms (Quailes strain), the fresh vaccine was highly protective (66%—78% efficacy), while lyophilized vaccine gave no clinical protection. Fresh vaccine also interfered significantly with intestinal proliferation of virulent S. typhi only 17% of the vaccinees excreted organisms as compared with 75% of the controls. Studies of protection in mice showed no difference between immunogen content of the fresh and the lyophilized vaccines. Field trials with streptomycin-dependent, oral typhoid vaccine must await development of a lyophilized product that will retain the protective properties of the vaccine.

Original languageEnglish (US)
Pages (from-to)424-429
Number of pages6
JournalJournal of Infectious Diseases
Volume133
Issue number4
DOIs
StatePublished - Apr 1976
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Attenuated, streptomycin-dependent salmonella typhi oral vaccine: Potentialdeleterious effects of lyophilization'. Together they form a unique fingerprint.

  • Cite this